Screener

R&D

Name: Supernus Pharmaceuticals R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Supernus Pharmaceuticals·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$26.93M	$22.12M	$29.37M	$27.83M	$39.44M
Total	$26.93M	$22.12M	$29.37M	$27.83M	$39.44M

Business SegmentsView metric